As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could prevent ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

The key player in SARS-CoV-2's infection process is the receptor binding domain (RBD) of the spike protein. The RBD determines how well the virus binds to ACE2, the human cellular receptor ...

The new virus, too, was discovered in the bats first..New coronavirus variant , China New Coronavirus , HKU5 COV-2 ...

CoV-2, a new merbecovirus found in bats across China, that utilises the ACE2 receptor for cellular entry—raising concerns ...

Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...

Ensitrelvir reduced transmission of SARS-CoV-2 by 67% when given to uninfected household contacts of a person with COVID-19 ...

This pairing of antibodies was shown to be effective against the initial SARS-CoV-2 virus that caused the ... to get a foothold and attach to the receptor-binding domain (RBD) of the virus ...

This pairing of antibodies was shown to be effective against the initial SARS-CoV-2 virus that caused the ... to get a foothold and attach to the receptor-binding domain, or RBD, of the virus ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could ...

This pairing of antibodies was shown to be effective against the initial SARS-CoV-2 virus that caused the ... to get a foothold and attach to the receptor-binding domain, or RBD, of the virus ...